Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Jiangsu Maysta Chemical Co., Ltd. (603041.SS)
Nanjing, CN
Jiangsu Maysta Chemical Co., Ltd., founded in 2000 and headquartered in Nanjing, China, is a subsidiary of Foshan Shunde District Demei Chemical Group Co., Ltd. The company's core business revolves around the international research, development, production, and distribution of organosilicon surfactants. Its product offerings include a comprehensive range of polyurethane (PU) foam stabilizers, tailored for applications in rigid foams, slab stock foams, high-resilience (HR) foams, shoe soles, and one-component foams (OCF), along with specific cell openers for rigid and HR foams. Furthermore, Jiangsu Maysta Chemical supplies PU catalysts crucial for both rigid and flexible foam manufacturing. These chemical solutions are extensively utilized across diverse sectors such as home appliances, furniture, construction, and the automotive industry.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.79% | -10.70% | -11.90% | -9.20% | -0.48% | +3.24% | +5.51% | +5.96% | -2.81% | -6.40% | -6.40% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+2.8% Q1'26: +14.4% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-11.4% Q1'26: +14.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+17.7% ★ Q1'26: +3.3% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+12.4% ★ Q1'26: +9.8% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+6.4% ★ Q1'26: +5.8% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.2% ★ Q1'26: +3.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.09× ★ Q1'26: 1.57× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|
| Revenue |
501.01M
est: 492.00M (+1.8%)
|
601.17M
est: 804.00M (-25.2%)
|
618.06M
est: 1.04B (-40.6%)
|
| EBITDA |
148.11M
est: 127.17M (+16.5%)
|
133.30M
est: 180.80M (-26.3%)
|
130.59M
est: 233.87M (-44.2%)
|
| EBIT |
129.34M
est: 103.00M (+25.6%)
|
78.20M
est: 134.81M (-42.0%)
|
76.87M
est: 174.38M (-55.9%)
|
| Net Income |
110.00M
est: 108.13M (+1.7%)
|
64.14M
est: 138.94M (-53.8%)
|
56.67M
est: 184.64M (-69.3%)
|
| SGA |
53.70M
est: 22.41M (+139.6%)
|
54.18M
est: 59.64M (-9.2%)
|
17.77M
est: 77.15M (-77.0%)
|
| EPS |
0.61
est: 0.59 (+3.4%)
|
0.35
est: 0.76 (-53.9%)
|
0.31
est: 1.01 (-69.3%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-28 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-27 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-26 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-25 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-22 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-21 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-20 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-19 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-18 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-15 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-14 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-13 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-12 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-11 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-08 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-29 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-28 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-27 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kaijin Xu | Financial Director & Accounting Supervisor | — | male |
| Yu Sun | Chairman & GM | — | male |
| Zhang Wei | Deputy GM & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603041.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
